Work

Secondary Macular Hole Closure With Sub-Tenon Triamcinolone Acetonide

Year: 2025

Type: article

Abstract: Purpose: To evaluate the efficacy and safety of sub-Tenon triamcinolone acetonide in the management of secondary full-thickness macular holes after vitreoretinal surgeries or traumatic injury. Methods: This case series includes 3 patients with secondary macular holes. All patients were treated with 40 mg sub-Tenon triamcinolone acetonide injections for macular holes. Results: Postinjection, the macular holes closed in 2 months, 2 weeks, and 1 month, respectively. Vision improved in all cases. The third patient experienced a significant increase in intraocular pressure, effectively managed with topical medications. No recurrence was observed at follow-up. Conclusions: Sub-Tenon triamcinolone acetonide is a promising therapeutic option for the management of secondary macular holes less than 200 µm in diameter, demonstrating efficacy in promoting hole closure and improving visual outcomes.

Source: Journal of VitreoRetinal Diseases

DOI: 10.1177/24741264251364009

Authors: Reza Azimi, Amr K. Hassan, Elina Ghafari, Baruch D. Kuppermann, Mitul C. Mehta

Institution: University of California, Irvine

Language: English

Topic: Retinal and Macular Surgery

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,900